Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 431

1.

Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas.

Gobbi H, Simpson JF, Jensen RA, Olson SJ, Page DL.

Mod Pathol. 2003 Sep;16(9):893-901.

2.

Low-grade (fibromatosis-like) spindle cell carcinoma of the breast.

Sneige N, Yaziji H, Mandavilli SR, Perez ER, Ordonez NG, Gown AM, Ayala A.

Am J Surg Pathol. 2001 Aug;25(8):1009-16.

PMID:
11474284
3.

Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence.

Gobbi H, Simpson JF, Borowsky A, Jensen RA, Page DL.

Cancer. 1999 May 15;85(10):2170-82.

PMID:
10326695
4.

Metaplastic carcinoma of the breast arising within complex sclerosing lesion: a report of five cases.

Denley H, Pinder SE, Tan PH, Sim CS, Brown R, Barker T, Gearty J, Elston CW, Ellis IO.

Histopathology. 2000 Mar;36(3):203-9.

PMID:
10692021
5.

Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.

Carter MR, Hornick JL, Lester S, Fletcher CD.

Am J Surg Pathol. 2006 Mar;30(3):300-9.

PMID:
16538049
6.

Fine-needle aspiration cytology of spindle cell lesions of the breast.

Chhieng DC, Cangiarella JF, Waisman J, Fernandez G, Cohen JM.

Cancer. 1999 Dec 25;87(6):359-71.

PMID:
10603190
7.

Metaplastic breast carcinoma: pathology and clinical outcome.

Bellino R, Arisio R, D'Addato F, Attini R, Durando A, Danese S, Bertone E, Grio R, Massobrio M.

Anticancer Res. 2003 Jan-Feb;23(1B):669-73.

PMID:
12680165
8.

Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients.

Adem C, Reynolds C, Adlakha H, Roche PC, Nascimento AG.

Histopathology. 2002 Jun;40(6):556-62.

PMID:
12047767
9.

Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.

Popnikolov NK, Cavone SM, Schultz PM, Garcia FU.

Mod Pathol. 2005 Dec;18(12):1535-41.

10.

Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.

Tan PH, Lui GG, Chiang G, Yap WM, Poh WT, Bay BH.

Histopathology. 2004 Oct;45(4):343-51.

PMID:
15469472
11.

The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.

Tse GM, Tan PH, Lui PC, Gilks CB, Poon CS, Ma TK, Law BK, Lam WW.

J Clin Pathol. 2007 Mar;60(3):315-20. Epub 2006 May 12.

12.

Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression.

Barnes PJ, Boutilier R, Chiasson D, Rayson D.

Breast Cancer Res Treat. 2005 May;91(2):173-8.

PMID:
15868445
13.

Sarcomatoid carcinoma of the penis: a clinicopathologic study of 15 cases.

Velazquez EF, Melamed J, Barreto JE, Aguero F, Cubilla AL.

Am J Surg Pathol. 2005 Sep;29(9):1152-8.

PMID:
16096403
14.

Atypia in inverted urothelial papillomas: pathology and prognostic significance.

Broussard JN, Tan PH, Epstein JI.

Hum Pathol. 2004 Dec;35(12):1499-504.

PMID:
15619209
15.

Keratin Expression Patterns in Stromal Cells of Benign Sclerosing Lesions of the Breast: A Potential Diagnostic Pitfall.

Oh EY, Collins LC.

Arch Pathol Lab Med. 2015 Sep;139(9):1143-8. doi: 10.5858/arpa.2014-0496-OA. Epub 2015 May 19.

PMID:
25989286
16.
17.

Fibrohistiocytic lipoma: twelve cases of a previously undescribed benign fatty tumor.

Marshall-Taylor C, Fanburg-Smith JC.

Ann Diagn Pathol. 2000 Dec;4(6):354-60.

PMID:
11149965
18.

[Pathologic diagnosis and differential diagnosis of low-grade adenosquamous carcinoma of breast and syringomatous adenoma of nipple].

Li J, Yang GZ, Jin H, Ding HY.

Zhonghua Bing Li Xue Za Zhi. 2012 May;41(5):301-4. doi: 10.3760/cma.j.issn.0529-5807.2012.05.004. Chinese.

PMID:
22883667
19.

Metaplastic breast carcinomas and their relationship with basal-like phenotype.

Cakir A, Gönül II, Uluoğlu O.

Turk Patoloji Derg. 2012;28(2):134-41. doi: 10.5146/tjpath.2012.01112.

20.

Supplemental Content

Support Center